• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃兹蛋白的下调抑制宫颈癌细胞的迁移能力。

Downregulation of Ezrin Suppresses Migration Potential in Cervical Cancer Cells.

作者信息

Hałas-Wiśniewska Marta, Arendt Wioletta, Grzanka Alina, Izdebska Magdalena

机构信息

Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85-092 Bydgoszcz, Poland.

出版信息

Pharmaceuticals (Basel). 2024 Dec 24;18(1):3. doi: 10.3390/ph18010003.

DOI:10.3390/ph18010003
PMID:39861066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769092/
Abstract

BACKGROUND

The literature reports that ezrin (EZR) is important as a linker between microfilaments and cellular environments. Moreover, it affects cancer cell migration, but the exact mechanism is not fully understood. In this study, we aimed to investigate the role of EZR in the migration of two different types of cervical cancer cells-from primary lesion (SiHa) and lymph node metastases (HT-3). In addition, we showed for the first time that a reduced EZR protein level affects the cellular response to the routinely used treatment with cisplatin.

METHODS

The most important stage of the study consisted of conducting a series of tests enabling the assessment of the migration potential of cervical cancer cells without altered EZR expression and with silenced protein expression.

RESULTS

Reducing the EZR level resulted in a decrease in the invasive and migration potential of SiHa and HT-3 cells' inhibition of colony formation, a decrease in adhesive properties, and a strong reorganization of F-actin with a dominance of cells with a mitotic catastrophe phenotype. A lower level of protein significantly reduces the motor skills of SiHa and HT-3 cervical cancer cells.

CONCLUSIONS

This significantly affects the assessment of EZR as a potential factor that can limit the development of metastases in targeted cancer therapy of cervical cancer.

摘要

背景

文献报道埃兹蛋白(EZR)作为微丝与细胞环境之间的连接蛋白具有重要作用。此外,它影响癌细胞迁移,但其确切机制尚未完全明确。在本研究中,我们旨在探究EZR在两种不同类型宫颈癌细胞(来自原发性病变的SiHa细胞和淋巴结转移灶的HT - 3细胞)迁移中的作用。此外,我们首次表明EZR蛋白水平降低会影响细胞对常规使用的顺铂治疗的反应。

方法

该研究最重要的阶段包括进行一系列测试,以评估EZR表达未改变以及蛋白表达沉默的宫颈癌细胞的迁移潜能。

结果

降低EZR水平导致SiHa和HT - 3细胞的侵袭和迁移潜能降低、集落形成受到抑制、黏附特性下降,以及F - 肌动蛋白发生强烈重组,具有有丝分裂灾难表型的细胞占优势。较低的蛋白水平显著降低了SiHa和HT - 3宫颈癌细胞的运动能力。

结论

这对将EZR评估为宫颈癌靶向癌症治疗中可限制转移发展的潜在因素具有重要影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/74b63ae1255f/pharmaceuticals-18-00003-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/788c8ee7d138/pharmaceuticals-18-00003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/3214a3f761c0/pharmaceuticals-18-00003-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/f48bdb03847f/pharmaceuticals-18-00003-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/228c12b8c340/pharmaceuticals-18-00003-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/8b0c39fba668/pharmaceuticals-18-00003-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/6e3647f947d3/pharmaceuticals-18-00003-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/d5a512b07d5b/pharmaceuticals-18-00003-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/284da1ed240a/pharmaceuticals-18-00003-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/74b63ae1255f/pharmaceuticals-18-00003-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/788c8ee7d138/pharmaceuticals-18-00003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/3214a3f761c0/pharmaceuticals-18-00003-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/f48bdb03847f/pharmaceuticals-18-00003-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/228c12b8c340/pharmaceuticals-18-00003-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/8b0c39fba668/pharmaceuticals-18-00003-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/6e3647f947d3/pharmaceuticals-18-00003-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/d5a512b07d5b/pharmaceuticals-18-00003-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/284da1ed240a/pharmaceuticals-18-00003-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/11769092/74b63ae1255f/pharmaceuticals-18-00003-g009.jpg

相似文献

1
Downregulation of Ezrin Suppresses Migration Potential in Cervical Cancer Cells.埃兹蛋白的下调抑制宫颈癌细胞的迁移能力。
Pharmaceuticals (Basel). 2024 Dec 24;18(1):3. doi: 10.3390/ph18010003.
2
Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells.转录组学分析鉴定出 ezrin 是宫颈癌和胃癌细胞中一个有潜力的可用药靶。
Clinics (Sao Paulo). 2024 Jul 6;79:100422. doi: 10.1016/j.clinsp.2024.100422. eCollection 2024.
3
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.埃兹蛋白的药理学抑制作用可降低急性淋巴细胞白血病细胞的增殖和侵袭表型。
Eur J Pharmacol. 2025 Jan 15;987:177161. doi: 10.1016/j.ejphar.2024.177161. Epub 2024 Nov 29.
4
Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro.敲低 Ezrin 抑制宫颈癌体外迁移和侵袭。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420930899. doi: 10.1177/2058738420930899.
5
EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.EZR通过激活FAK/AKT信号通路促进胰腺癌的增殖和转移。
Cancer Cell Int. 2021 Oct 9;21(1):521. doi: 10.1186/s12935-021-02222-1.
6
Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.活体成像显示,系统抑制埃兹蛋白可阻碍乳腺癌细胞迁移和淋巴结转移。
Breast Cancer Res. 2019 Jan 24;21(1):12. doi: 10.1186/s13058-018-1079-7.
7
High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients.EZR(埃兹蛋白)基因的高表达与乳腺癌患者总体生存率降低相关。
Thorac Cancer. 2019 Oct;10(10):1953-1961. doi: 10.1111/1759-7714.13174. Epub 2019 Aug 26.
8
NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells.NSC305787,一种药理学的埃兹蛋白抑制剂,在胰腺癌细胞中表现出抗肿瘤活性。
Invest New Drugs. 2022 Aug;40(4):728-737. doi: 10.1007/s10637-022-01249-z. Epub 2022 Apr 28.
9
Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways.胰腺癌细胞来源的小细胞外囊泡 ezrin 通过 STAT3 和 YAP-1 信号通路激活成纤维细胞,从而加剧癌症转移。
Mol Oncol. 2023 Aug;17(8):1628-1647. doi: 10.1002/1878-0261.13442. Epub 2023 May 12.
10
[FABP5 promotes cell growth, invasion and metastasis in cervical cancer].[脂肪酸结合蛋白5促进宫颈癌细胞的生长、侵袭和转移]
Zhonghua Zhong Liu Za Zhi. 2019 Mar 23;41(3):200-207. doi: 10.3760/cma.j.issn.0253-3766.2019.03.009.

引用本文的文献

1
Targeting Skin Neoplasms: A Review of Berberine's Anticancer Properties.靶向皮肤肿瘤:小檗碱抗癌特性综述
Cells. 2025 Jul 8;14(14):1041. doi: 10.3390/cells14141041.

本文引用的文献

1
Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies.顺铂诱导毒性的研究进展:分子机制与保护策略。
Eur J Pharm Sci. 2024 Dec 1;203:106939. doi: 10.1016/j.ejps.2024.106939. Epub 2024 Oct 17.
2
Moesin and Ezrin as New Promising Markers for Early Detection of Endometrial Carcinoma: An Immunohistochemical Study.结蛋白和埃兹蛋白作为子宫内膜癌早期检测的新的有前途的标志物:免疫组织化学研究。
Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3243-3246. doi: 10.31557/APJCP.2023.24.9.3243.
3
Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis.
易转移:埃兹蛋白在转移中的关键作用。
Cells. 2023 Jun 14;12(12):1620. doi: 10.3390/cells12121620.
4
Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target.Ezrin 失控促进癌症进展和转移:诱人的治疗靶点。
Biochim Biophys Acta Rev Cancer. 2022 Jul;1877(4):188753. doi: 10.1016/j.bbcan.2022.188753. Epub 2022 Jun 22.
5
Cervical cancer therapies: Current challenges and future perspectives.宫颈癌治疗:当前的挑战与未来展望。
Tumour Virus Res. 2022 Jun;13:200238. doi: 10.1016/j.tvr.2022.200238. Epub 2022 Apr 20.
6
Dose-Intense Cisplatin-Based Neoadjuvant Chemotherapy Increases Survival in Advanced Cervical Cancer: An Up-to-Date Meta-Analysis.基于顺铂的剂量密集新辅助化疗可提高晚期宫颈癌患者的生存率:一项最新的荟萃分析。
Cancers (Basel). 2022 Feb 8;14(3):842. doi: 10.3390/cancers14030842.
7
Downregulation of MMP-9 Enhances the Anti-Migratory Effect of Cyclophosphamide in MDA-MB-231 and MCF-7 Breast Cancer Cell Lines.下调 MMP-9 增强环磷酰胺对 MDA-MB-231 和 MCF-7 乳腺癌细胞系的抗迁移作用。
Int J Mol Sci. 2021 Nov 26;22(23):12783. doi: 10.3390/ijms222312783.
8
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?生长因子、PI3K/AKT/mTOR和MAPK信号通路在结直肠癌发病机制中的作用:我们目前的进展如何?
Int J Mol Sci. 2021 Sep 23;22(19):10260. doi: 10.3390/ijms221910260.
9
Ezrin Promotes the Proliferation, Migration, and Invasion of Ovarian Cancer Cells.埃兹蛋白促进卵巢癌细胞的增殖、迁移和侵袭。
Biomed Environ Sci. 2021 Feb 20;34(2):139-151. doi: 10.3967/bes2021.020.
10
Targeting metastatic cancer.针对转移性癌症。
Nat Med. 2021 Jan;27(1):34-44. doi: 10.1038/s41591-020-01195-4. Epub 2021 Jan 13.